A phase 2 GALAXY study presented at the ESMO Gastrointestinal Cancers Congress 2026 suggests that circulating tumor DNA (ctDNA) testing…
Browsing: Clinical Updates
A new study suggests that disorders of gut-brain interaction (DGBIs)—such as irritable bowel syndrome (IBS) and functional dyspepsia—rarely occur in…
The ESMO Gastrointestinal Cancers Congress 2026 featured several important studies that could influence the future of gastrointestinal cancer treatment, although…
Freenome reported positive results from a pivotal clinical validation study of its next-generation SimpleScreen™ CRC blood test, which met all…
An updated POWER (Practice Guide on Obesity and Weight Management, Education, and Resources) framework calls on gastroenterologists and hepatologists to…
A randomized, sham-controlled study published in JAMA Internal Medicine found that a single fecal microbiota transplantation (FMT) session did not…
A cost-effectiveness analysis of the IBD-BOOST randomized controlled trial found that a facilitator-supported digital self-management program is highly likely to…
Experts at IDWeek 2025 emphasized that diagnosing Clostridioides difficile infection (CDI) now requires greater clinical judgment, as highly sensitive molecular…
The American College of Gastroenterology and the American Gastroenterological Association have issued statements highlighting some concerns and important factors to…
Zobair Younossi, Chairman of the Global NASH/MASH Council and Professor of Medicine at Georgetown University, reviewed the latest global consensus…